RE: Newsflow as expectedToday 07:55
Fusion Antibodies presents at the Proactive One2One Investor Conference - January 11th 2024
“I know antibodies are worth a lot of money so there is an example recently, Novartis bought a company called Calipso to get hold of one antibody called Cali002, $425m in order to do so, what you may not have known is we humanised that antibody” - Adrian
DR5 antibodies are worth a huge amount more just to give you a sense of the potential value of this project, don't get me started on Optimal too!